KohneC.H.: Chemotherapy in elderly patients with colorectal cancer. Ann Oncol, 12: 435–442, 2001.
2.
RiesL.A.G.: SEER cancer statistic review, 1973-1993: tables and graphs.Bethesda, National Institutes of Health, United States Public Health Service, 1996.
3.
MantonK.G.: Survival after age of 80 in United States, Sweden, France, England and Japan. N Engl J Med, 333: 1232–1235, 1995.
4.
ExtermannM.: Assessment of the older cancer patient. Hematol Oncol Clin North Am, 14: 63–77, 2000.
5.
BerettaG.: Should we consider the weekly (w) chemotherapy (CT) with fluorouracil (F) + racemic folinic acid (f) a standard treatment for advanced/metastatic carcinoma of digestive tract (DTC) in elderly patients (pts)?Proc Am Soc Clin Oncol, 16: 259a, 1997.
6.
BeggC.B.: Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer, 52: 1986–1992, 1983.
7.
ChiaraS.: Advanced colorectal cancer in the elderly: Results of consecutive trials with 5-fluorouracil-based chemotherapy. Cancer Chemother Pharmacol, 42: 336–340, 1998.
8.
PopescuR.A.: Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol, 17: 2412–2418, 1999.
9.
SteinB.N.: Age and sex are independent predictors of 5-FU toxicity. Analysis of a large scale phase III trial Cancer, 75: 11–17, 1995.
10.
FerrariV.D.: Tegafur (T) plus folinic acid (FA) as first line treatment of advanced colorectal cancer (ACC) in patients (PTS) aged over 70 years. Ann Oncol, 11: 54, 2000.
11.
Diaz RubioE.: UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients. Oncology (Huntingt), 13: 35–40, 1999.
12.
AbadA.: A preliminary report of a phase II trial. UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Spanish Group for the Treatment of Gastrointestinal Tumors (TTd Group). Oncology (Untingt), 11: 53–57, 1997.
13.
MattioliR.: Advanced colorectal cancer in elderly patients: tolerance and efficacy of leucovorin and fluorouracil bolus plus continuous infusion. Anticancer Res, 21: 489–492, 2001.
14.
BerrettaM.: Comparison between elderly and non elderly patients (pts) of efficacy and tolerability of FOLFOX2 schedule in advanced colorectal cancer (COL). Proc Am Soc Clin Oncol, 2195 abs, 2001.
